Biomarin Pharmaceutical reported $216.82M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 78.11M 11.79M
Acorda Therapeutics ACOR:US USD 23M 7.07M
Agios Pharmaceuticals AGIO:US USD 29.12M 859K
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Amgen AMGN:US USD 1.47B 181M
Bayer BAYN:GR EUR 4.08B 393M
Biogen BIIB:US USD 563.3M 9.3M
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Gilead Sciences GILD:US USD 2.02B 807M
Insmed INSM:US USD 75.58M 15.61M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
IONIS PHARMACEUT IONS:US USD 34.42M 614K
Moderna Inc MRNA:US USD 278M 67M
Neurocrine Biosciences NBIX:US USD 186.3M 3.5M
Ptc Therapeutics PTCT:US USD 80.12M 226K
Puma Biotechnology PBYI:US USD 23.96M 3.38M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Roche Holding ROG:VX 5.64B 899M
Sangamo Biosciences SGMO:US USD 16.24M 1.14M
Sarepta Therapeutics SRPT:US USD 104.79M 49.53M
Seattle Genetics SGEN:US USD 210.38M 9.88M
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M
United Therapeutics UTHR:US USD 98.4M 43.1M
Vertex Pharmaceuticals VRTX:US USD 246.8M 31.5M
YTE INCY:US USD 266.46M 13.18M